EVENT
WPI-Bio2Q Open Seminar, Harvey Lodish, Ph.D.
June 19, 2024
On Wednesday, June 12, the Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q) held an open seminar at Shinanomachi Campus .
16:00 -17:30 Wednesday, June 12, 2024
“New Technologies and Building Successful Biotechnology Companies to Treat Disease: A Personal History”
Harvey F. Lodish, PhD
Professor of Biology and Professor of Biological Engineering, Massachusetts Institute of Technology
Lead author, “Molecular Cell Biology”
Founder/scientific board member: Genzyme, Millennium Pharmaceuticals, Rubius Therapeutics, Tevard
Prof. Lodish highlighted the connection between academia and entrepreneurship in biotechnology, covering key aspects of starting a biotech company, intellectual property, and assembling a team with diverse expertise. The importance of scientists leveraging their expertise by consulting for or founding companies and the advantage of research institutes being located near biotech companies for collaboration was also discussed.
More Bio2Q News
WPI-Bio2Q Open Seminar on Sept. 11 (Wed) at Shinanomachi Campus, Gabriel Nuñez, ...
Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q) will hold an open seminar as follows: Title: “Host-Microbiot...
WPI-Bio2Q Open Seminar, Tsutomu Suzuki, Ph.D. (September 10) for Keio University...
On Tuesday, September 10, the Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q) will hold an open seminar at the ...
WPI-Bio2Q now recruiting administrative staff 事務スタッフ募集中(9/29締切)
WPI-Bio2Q Administrative Office is currently hiring administrative staff for FY2024. We look forward to receiving applications from cand...
Prof. Takahiko Koyama now Recruiting Research Assistants (臨時職員 募集中)
Prof. Takahiko Koyama, specializing in Quantum Computing, Artificial Intelligence in Life Sciences, is currently hiring research assistants....
Bio2Q Members - Dr. HAOWEI LI
Introducing new member of Bio2Q We are pleased to welcome Dr. Haowei Li as a postdoctoral fellow at Bio2 core of Bio2Q. The greeting fr...